Upcoming events on PFIZER INC. |
|
01/28/21 | | Ex-dividend day for |
02/02/21 | | FY 2020 Earnings Release |
02/02/21 | 10:00am | | FY 2020 Earnings Call |
05/04/21 | | Q1 2021 Earnings Release (Projected) |
|
Past events on PFIZER INC. |
|
01/12/21 | 10:00am | | JP Morgan Healthcare Conference |
12/07/20 | | American Society of Hematology Meeting |
11/18/20 | 09:50am | | Wolfe Virtual Healthcare Conference |
11/17/20 | | Spin off |
|
Upcoming sector events for PFIZER INC. |
|
|
|
Past sector events for PFIZER INC. |
|
|
|
Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales M $ |
Released Forecast Spread | 48 851 48 399 0,93% | 52 824 52 891 -0,13% | 52 546 52 524 0,04% | 53 647 53 582 0,12% | 51 750 51 807 -0,11% | 48 425
|
Operating income (EBITDA) M $ |
Released Forecast Spread | 22 880 20 437 12% | 20 309 20 776 -2,2% | 21 172 21 875 -3,2% | 21 814 21 615 0,92% | 21 097 22 824 -7,6% | 22 302
|
Operating profit (EBIT) M $ |
Released Forecast Spread | 17 723 17 769 -0,26% | 18 480 18 819 -1,8% | 19 468 19 859 -2,0% | 20 042 19 998 0,22% | 19 420 19 883 -2,3% | 17 923
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 8 965 12 544 -29% | 8 351 11 125 -25% | 12 305 14 925 -18% | 11 885 16 386 -27% | 17 682 22 426 -21% | 13 153
|
Net income M $ |
Released Forecast Spread | 7 745 9 766 -21% | 7 215 8 882 -19% | 21 308 11 574 84% | 11 153 14 121 -21% | 16 273 19 053 -15% | 19 798
|
EPS $ |
Released Forecast Spread | 1,24 1,46 -15% | 1,17 1,36 -14% | 3,52 1,88 87% | 1,87 2,38 -21% | 2,87 3,40 -16% | 3,10
| Announcement Date | 02/02/2016 | 01/31/2017 | 01/30/2018 | 01/29/2019 | 01/28/2020 | |
|
|
Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales M $ |
Released Forecast Spread | 13 466 13 298 1,3% | 13 298 13 533 -1,7% | 13 976 13 929 0,34% | 13 118 13 012 0,82% | 13 264 13 430 -1,2% | 12 680 12 365 2,5% | 12 688 12 728 -0,31% | 12 028 11 743 2,4% | 11 801 11 553 2,1% | 12 131 12 298 -1,4% | 12 012
| 13 045
| 13 283
| 13 059
| 13 069
|
Operating income (EBITDA) M $ |
Released Forecast Spread | 5 665 5 677 -0,21% | 5 517 5 439 1,4% | 4 917 4 629 6,2% | 6 061 5 672 6,9% | 5 763 5 640 2,2% | 5 426 4 475 21% | 3 826 4 218 -9,3% | 5 539 5 220 6,1% | 5 279 5 180 1,9% | 5 595 5 090 9,9% | 3 944
| 5 483
| 5 408
| 5 403
| 5 057
|
Operating profit (EBIT) M $ |
Released Forecast Spread | 5 224 5 279 -1,0% | 5 085 5 196 -2,1% | 4 459 4 356 2,4% | 5 636 5 148 9,5% | 5 352 4 961 7,9% | 5 013 4 058 24% | 3 418 3 819 -10% | 5 135 4 535 13% | 4 791 4 175 15% | 4 333 4 505 -3,8% | 3 722
| 4 999
| 4 999
| 4 999
| 4 999
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 4 527 4 189 8,1% |
|
| 4 323 3 682 17% |
|
|
|
|
|
|
|
|
|
|
|
Net income M $ |
Released Forecast Spread | 3 872 3 263 19% | 4 114 3 935 4,6% | -394 2 689 -115% | 3 884 3 539 9,7% | 5 046 3 658 38% | 7 680 3 245 137% | -337 3 241 -110% | 3 401
|
| 2 194 3 215 -32% | 3 376
|
|
|
|
|
EPS $ |
Released Forecast Spread | 0,65 0,56 16% | 0,69 0,58 19% | -0,07 0,49 -114% | 0,68 0,60 13% | 0,89 0,65 38% | 1,36 0,53 158% | -0,06 0,53 -111% | 0,61 0,47 29% |
| 0,39 0,57 -32% | 0,34
|
|
|
|
| Announcement Date | 07/31/2018 | 10/30/2018 | 01/29/2019 | 04/30/2019 | 07/29/2019 | 10/29/2019 | 01/28/2020 | 04/28/2020 | 07/28/2020 | 10/27/2020 | | | | | |
|
Financial data source © 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
REFILE-Pfizer forecasts 2021 earnings of $3 to $3.10 per share |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|